Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.00 -0.03 (-2.89%)
At close: Oct 1, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Return on Equity [ROE] (2013 - 2026)

Updated

Phio Pharmaceuticals (PHIO) reported Return on Equity [ROE] of -88.82% for Q2 2026, down 26.44 percentage points from -62.38% a year earlier and down 29.08 percentage points from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2025, Phio Pharmaceuticals posted Return on Equity [ROE] of -69.96%, up 44.96 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of +23.76 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -114.93% in FY2024 (+1.66 pp), -116.59% in FY2023 (-46.52 pp), -70.06% in FY2022 (+5.97 pp) and -76.04% in FY2021 (+17.69 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2024.
  • Year over year, Return on Equity [ROE] gained in five of the last eight quarters, with an average year-over-year change of +40.53 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q2 2025 (a gain of 124.14 percentage points); the low point was Q2 2023 (a drop of 76.88 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -59.74% (Q1 2026), -57.03% (Q4 2025) and -78.38% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Phio Pharmaceuticals 11.97 Mn 11.97 Mn - -88.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -88.82%
Mar 31, 2026 -59.74%
Dec 31, 2025 -57.03%
Sep 30, 2025 -78.38%
Jun 30, 2025 -62.38%
Mar 31, 2025 -79.23%
Dec 31, 2024 -149.47%
Sep 30, 2024 -171.88%
Jun 30, 2024 -186.52%
Mar 31, 2024 -140.66%
Dec 31, 2023 -144.87%
Sep 30, 2023 -136.18%
Jun 30, 2023 -144.64%
Mar 31, 2023 -136.91%
Dec 31, 2022 -94.09%
Sep 30, 2022 -79.80%
Jun 30, 2022 -67.76%
Mar 31, 2022 -60.47%
Dec 31, 2021 -57.28%
Sep 30, 2021 -46.30%
API Access

Phio Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHIO&period=max&api_key=YOUR_API_KEY